• About Amgen
  • Science
  • Corporate Philanthropy
  • Sitemap
  • Search
  • Privacy & Terms
  • Contact Us
Amgen
  • Patients
  • Careers
  • Media
  • print
  • mail
  • Home
  • Medical Professionals
  • Products

  • Overview
  • Products
  • Disease Information
  • Clinical Trials
  • Resources
  • R&D Vision
  • Patient Assistance
  • Medical Information
Products
The following table provides the prescribing information for Amgen Canada’s major approved products.  Due to differences in Global labelling, this information is intended for residents of Canada only.  Canadian regulations limit the amount and scope of information we can provide on our prescription drugs.

Aranesp ®
Enbrel ®
Kepivance ®
Kineret ®
Neulasta ®
Neupogen ®
Sensipar ®

footer